Dr. Mark Levine is a Professor in the Department of Oncology at McMaster University, Hamilton, Ontario, Canada. He holds the Buffett Taylor Chair in Breast Cancer Research at McMaster University. He practiced medical oncology for 36 years and is still devoting time to research.
He received his medical degree from McGill University and completed training in hematology and oncology at Duke University Medical Centre, returning to McMaster to pursue additional training in Epidemiology and Biostatistics at McMaster University.
Dr. Levine has been an active researcher in clinical trials and health services research in the areas of breast cancer and venous thromboembolism. A number of the trials he has conducted have been landmark studies influencing healthcare in both Canada and internationally. Through this work he helped establish the Ontario Clinical Oncology Group (OCOG) and led the group in the position of Director for over 35 years, from 1984-2021.
Dr. Levine also has over 310 publications in peer-reviewed journals and has brought significant research funding to McMaster University.
Dr. Levine has held numerous prominent professional positions throughout his career serving as Chairman of Health Canada's Steering Committee on Clinical Practice Guidelines for the Care & Treatment of Breast Cancer, as well as Associate and Consultant Editor of the Journal of Clinical Oncology. He was an Associate Editor for JAMA Network Open.
In addition, Dr. Levine has been the recipient of several prestigious accolades that include the O. Harold Warwick Prize from the National Cancer Institute of Canada and Order of Canada both acknowledging life-time accomplishments and contributions to the medical field as a clinical researcher.